Canton Strategic Holdings (CNTN) Interest Expenses (2021 - 2025)
Canton Strategic Holdings (CNTN) reported Interest Expenses of $4065.0 for Q4 2025, up 436.28% on a YoY basis from $758.0 in Q4 2024, and down 57.87% quarter-over-quarter from $9648.0 in Q3 2025.
Canton Strategic Holdings (CNTN) Interest Expenses (2021 - 2025) Analysis & Trends
Canton Strategic Holdings has reported Interest Expenses for 5 years, with the latest figure at $4065.0 in Q4 2025.
- For the quarter ending Q4 2025, Interest Expenses rose 436.28% year-over-year to $4065.0; the trailing twelve-month figure through Mar 2026 stood at $19874.0 (up 13.86% YoY), and the FY2025 full-year result was $28345.0, up 107.14% from the prior year.
- Interest Expenses for Q4 2025 stood at $4065.0, down from $9648.0 in the prior quarter.
- The five-year high for Interest Expenses was $1.6 million in Q1 2022, with the low at -$8756.0 in Q4 2022.
- Historically, Interest Expenses has averaged $137826.0 across 5 years, with a median of $6149.5 in 2023.
- The largest YoY upside for Interest Expenses was 979.69% in 2022 against a maximum downside of 103.39% in 2022.
- Canton Strategic Holdings' Interest Expenses stood at $258000.0 in 2021, then plunged by 103.39% to -$8756.0 in 2022, then surged by 104.04% to $354.0 in 2023, then surged by 114.12% to $758.0 in 2024, then surged by 436.28% to $4065.0 in 2025.
- The last three Interest Expenses figures came in at $4065.0 (Q4 2025), $9648.0 (Q3 2025), and $6161.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Canton Strategic Holdings | 699.97 Mn | 658.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,065.00 |
| Dec 31, 2025 | 4,065.00 |
| Sep 30, 2025 | 9,648.00 |
| Sep 30, 2025 | 9,648.00 |
| Jun 30, 2025 | 6,161.00 |
| Jun 30, 2025 | 6,161.00 |
| Mar 31, 2025 | 8,471.00 |
| Mar 31, 2025 | 8,471.00 |
| Dec 31, 2024 | 758.00 |
| Dec 31, 2024 | 758.00 |
| Sep 30, 2024 | 3,009.00 |
| Sep 30, 2024 | 3,009.00 |
| Jun 30, 2024 | 5,217.00 |
| Jun 30, 2024 | 5,217.00 |
| Mar 31, 2024 | 4,700.00 |
| Mar 31, 2024 | 4,700.00 |
| Dec 31, 2023 | 354.00 |
| Dec 31, 2023 | 354.00 |
| Sep 30, 2023 | 3,496.00 |
| Sep 30, 2023 | 3,496.00 |